Monoclonal IgM antibodies to GM1 and asialo‐GM1 in chronic neuropathies cross‐react with Compylobacter jejuni lipopolysaccharides

  • I. Wirguin
  • , Lj Suturkova‐Milosevic
  • , P. Della‐Latta
  • , T. Fisher
  • , R. H. Brown
  • , N. Latov

Research output: Contribution to journalArticlepeer-review

68 Scopus citations

Abstract

We tested monoclonal IgM anti‐GM1 and asialo‐GM1 antibodies from 6 patients with chronic motor neuropathies for binding to lipopolysccharides (LPS) from three strains of Campylobacter jejuni. Four of the 6 patients showed strong reactivity with LPS from at least one of the three C. jejuni strains tested as shown by enzyme‐linked immunosorbent assay or western blot. Preabsorption with GM1 or asialo‐GM1, or blocking with cholera toxin, prevented antibody binding to LPS. These studies indicate that human anti‐GM1 or anti–asialo‐GM1 antibodies cross‐react with LPS from certain strains of C. jejuni, and that bacterial LPS might provide antigenic stimuli for the activation of B cells expressing anti‐GM1 antibodies.

Original languageEnglish
Pages (from-to)698-703
Number of pages6
JournalAnnals of Neurology
Volume35
Issue number6
DOIs
StatePublished - 1 Jan 1994
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Fingerprint

Dive into the research topics of 'Monoclonal IgM antibodies to GM1 and asialo‐GM1 in chronic neuropathies cross‐react with Compylobacter jejuni lipopolysaccharides'. Together they form a unique fingerprint.

Cite this